Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.
about
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infectionsJC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?Bacteriophages and Their Immunological Applications against Infectious Threats.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designThe Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in miceNeutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV InfectionMultiantibody strategies for HIV.Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.HCV E2 core structures and mAbs: something is still missing.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.A Biologically-validated HCV E1E2 Heterodimer Structural Model.Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.Innate and Adaptive Immune Responses in Chronic HCV Infection.Predicting the Effectiveness of Hepatitis C Virus Neutralizing Antibodies by Bioinformatic Analysis of Conserved Epitope Residues Using Public Sequence Data.HCV envelope glycoproteins in evirion assembly and entry
P2860
Q24289014-90402015-0B3A-44FF-A188-31E4DD5AA448Q26852060-B4600B47-B399-4434-A0B6-AF25B4C6C71DQ30234522-4B65FF7E-1E30-4478-9B47-15F918A99131Q30374314-50A08B07-B933-4D91-83E4-0691BF64AA33Q34481429-D949F9CB-2011-4487-9E8A-998D59CDEEB8Q35385403-D5D9D50E-A011-43B9-B781-04E34D9CBD81Q36404194-1DB9C5C4-73E8-41EB-B000-0C8879487C95Q36432725-9A5A21AD-FC68-47DA-92E9-7D07C648F288Q36682313-424AFB37-ADCD-47D2-A4AB-B96824D5DF93Q36811958-FD5D9B15-5D36-4455-B58E-66A8BD77FE6CQ38120526-E06BADC3-DC76-44FE-A81A-FA4577A5B0B2Q38128299-DAD72139-DA01-4EC2-86AE-0D831E820C5EQ38244787-69EED124-6242-4D67-8138-4E7A35F806A0Q38417056-CCD9B4D4-6601-48F0-AE92-8E890ECF37E3Q40288437-5C0DCB1F-522F-49D5-91F3-D154D9E414B3Q40761630-2F40C6B6-DE93-4A96-AFC6-CE0DC9152C1EQ41035955-663935B1-F131-4D93-A17C-EDB731929D12Q55657826-91B3F3B8-95D1-4C56-9D4C-8323C4C8F44FQ56910948-8701A1C9-15EF-4873-A2DE-85C9EA1A5F55
P2860
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-hepatitis C virus E2 (HCV ...... d neutralization interference.
@en
Anti-hepatitis C virus E2
@nl
type
label
Anti-hepatitis C virus E2 (HCV ...... d neutralization interference.
@en
Anti-hepatitis C virus E2
@nl
prefLabel
Anti-hepatitis C virus E2 (HCV ...... d neutralization interference.
@en
Anti-hepatitis C virus E2
@nl
P2093
P50
P1433
P1476
Anti-hepatitis C virus E2 (HCV ...... nd neutralization interference
@en
P2093
Laura Solforosi
Roberta A Diotti
Roberto Burioni
P356
10.1016/J.ANTIVIRAL.2012.07.013
P577
2012-08-07T00:00:00Z